Summary by Futu AI
Health International Medical Group Limited (“HealthCare International Medical”) issued a profit warning on 14 March 2024, expecting a consolidated loss of approximately HK$1.65 billion to HK$2.23 billion for the year ended 31 December 2023 and a comprehensive loss of approximately HK$1.35 billion to HK$1.83 million for the year ended 31 December 2023. In comparison, shareholders who earned approximately HK$1,530 million in the same period in 2022 accounted for a consolidated profit and an aggregate profit of approximately HK$4,950 million. The main reasons for this loss include increased demand for medical services, contributions following the acquisition of Central Medical Holdings Limited, increased losses in fair value of investment properties and a significant increase in asset impairment losses. THE COMPANY IS CURRENTLY EVALUATING AND VALUING THE RELATED ASSETS AND WILL DISCLOSE FINAL RESULTS AND OTHER DETAILS IN THE ANNUAL RESULTS ANNOUNCEMENT.